ResearcherMerck & Co., Inc., Rahway, NJ, USA (United States)Active in the last 2 years

Dominic Muston

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4876-7940; OpenAlex author ID A5037841861. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer. Last author DOI 10.1016/j.pan.2024.01.005 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Neeharika Agnihotri · 1 shared paper, 2024 · strength 0.24
- Paper Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic … DOI 10.1016/j.pan.2024.01.005 ↗
Hyun Kyoo Yoo · 1 shared paper, 2024 · strength 0.24
- Paper Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic … DOI 10.1016/j.pan.2024.01.005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.